Literature DB >> 24011762

Adolescence metabolic syndrome or adiposity and early adult metabolic syndrome.

Farhad Hosseinpanah1, Golaleh Asghari, Maryam Barzin, Sahar Ghareh, Fereidoun Azizi.   

Abstract

OBJECTIVE: To investigate the predictive role of adolescent metabolic syndrome (MetS) in development of early adult MetS, independent of adult body mass index (BMI). STUDY
DESIGN: 1424 adolescents (639 boys), participants of the Tehran Lipid and Glucose Study, followed for 10.4 years, were analyzed and logistic regression models were developed. Using the areas under the receiver operating characteristic curve, the discriminatory ability of adolescent MetS and overweight or obesity was evaluated. Net reclassification improvement was calculated to determine the accuracy of classification by adolescent MetS in place of overweight or obesity.
RESULTS: The mean ± SD of age and BMI were 14.6 ± 2.2 years and 20.3 ± 4.2 kg/m(2), respectively. The prevalence of MetS was 13.3% and 14.6% at baseline and after follow-up, respectively. The risk of developing early adult MetS among subjects who were overweight or obese in adolescence but nonobese as adults (OR: 1.65) was lower than the risk among subjects who were obese as adults but nonobese as adolescents (OR: 8.45). After adjustment for adult BMI, adolescent MetS and overweight or obesity did not show any association with the risk of adult MetS. Area under the receiver operating characteristic curve was higher for obesity (0.619) than MetS (0.589) and the net reclassification improvement value for MetS was 1.5% (P = .398).
CONCLUSION: Adolescent MetS or adiposity did not predict early adult MetS independent of adult BMI. The addition of adolescent MetS to obesity does not improve the predictive power for early adult MetS.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  BMI; Body mass index; HDL-C; High-density lipoprotein cholesterol; MetS; Metabolic syndrome; NPV; NRI; Negative predictive value; Net reclassification improvement; PPV; Positive predictive value; ROC; Receiver operating characteristic; TG; TLGS; Tehran Lipid and Glucose Study; Triglyceride; WC; Waist circumference

Mesh:

Year:  2013        PMID: 24011762     DOI: 10.1016/j.jpeds.2013.07.032

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2016-05-25       Impact factor: 3.942

2.  Metabolic risk assessment in children and adolescents using the tri-ponderal mass index.

Authors:  Young-Jun Seo; Young Suk Shim; Hae Sang Lee; Jin Soon Hwang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

Review 3.  Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis.

Authors:  Azad Fatahi; Amin Doosti-Irani; Zahra Cheraghi
Journal:  Int J Prev Med       Date:  2020-06-03

Review 4.  Overweight and Obesity: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Maryam Barzin; Majid Valizadeh; Sara Serahati; Maryam Mahdavi; Fereidoun Azizi; Farhad Hosseinpanah
Journal:  Int J Endocrinol Metab       Date:  2018-10-23

Review 5.  Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Firoozeh Hosseini-Esfahani; Zahra Bahadoran; Nazanin Moslehi; Golaleh Asghari; Emad Yuzbashian; Somayeh Hosseinpour-Niazi; Parvin Mirmiran; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2018-10-21

Review 6.  Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Davood Khalili; Fereidoun Azizi; Samaneh Asgari; Azita Zadeh-Vakili; Amir Abbas Momenan; Arash Ghanbarian; Fatemeh Eskandari; Farhad Sheikholeslami; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-13

7.  Association between preventable risk factors and metabolic syndrome.

Authors:  Hamoud A Al Shehri; Abdulrahman K Al Asmari; Haseeb A Khan; Saud Al Omani; Saeed G Kadasah; Ghaleb B Horaib; Ahmed Al Buraidi; Abdullah A Al Sharif; Fayez S Mohammed; Rajamohamed Abbasmanthiri; Nasreddien M Osman
Journal:  Open Med (Wars)       Date:  2022-02-21

Review 8.  The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance.

Authors:  Carolin Reisinger; Benedicta N Nkeh-Chungag; Per Morten Fredriksen; Nandu Goswami
Journal:  Int J Obes (Lond)       Date:  2020-11-18       Impact factor: 5.095

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.